The Increase of the Magnitude of Spontaneous Viral Blips in Some Participants of Phase II Clinical Trial of Therapeutic Optimized HIV DNA Vaccine Candidate

We developed a candidate DNA vaccine called “DNA-4”consisting of 4 plasmid DNAs encoding Nef, Gag, Pol(rt), and gp140 HIV-1 proteins. The vaccine was found to be safe and immunogenic in a phase I clinical trial. Here we present the results of a phase II clinical trial of &#82...

Full description

Bibliographic Details
Main Authors: Ekaterina Akulova, Boris Murashev, Sergey Verevochkin, Alexey Masharsky, Ruslan Al-Shekhadat, Valeriy Poddubnyy, Olga Zozulya, Natalia Vostokova, Andrei P. Kozlov
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/7/3/92